Prelude Therapeutics to Participate in Three Healthcare Investor Conferences in May
27 avr. 2023 08h30 HE
|
Prelude Therapeutics, Inc.
WILMINGTON, Del., April 27, 2023 (GLOBE NEWSWIRE) -- Prelude Therapeutics Incorporated (Nasdaq: PRLD), a clinical-stage precision oncology company, today announced that company executives will...
Incannex to Participate in the Prestigious H.C. Wainwright 24th Annual Global Investment Conference
08 sept. 2022 09h15 HE
|
Incannex Healthcare
MELBOURNE, Australia, Sept. 08, 2022 (GLOBE NEWSWIRE) -- Incannex Healthcare Limited (Nasdaq: IXHL) (ASX: IHL), (‘Incannex’ or the ‘Company’) a pharmaceutical company developing medicinal...
Prelude Therapeutics To Participate in Upcoming HC Wainwright and Morgan Stanley Healthcare Conferences
06 sept. 2022 08h00 HE
|
Prelude Therapeutics, Inc.
WILMINGTON, Del., Sept. 06, 2022 (GLOBE NEWSWIRE) -- Prelude Therapeutics Incorporated (Prelude) (Nasdaq: PRLD), a clinical-stage precision oncology company, announced today that the company will be...
Cingulate to Present at H.C. Wainwright Global Investment Conference
18 mai 2022 17h20 HE
|
Cingulate Inc.
KANSAS CITY, Kan., May 18, 2022 (GLOBE NEWSWIRE) -- Cingulate Inc. (NASDAQ: CING), a clinical-stage biopharmaceutical company utilizing its proprietary Precision Timed Release™ (PTR™) drug delivery...
Celyad Oncology to Present at the H.C. Wainwright Global Investment Conference
17 mai 2022 16h05 HE
|
Celyad Oncology SA
MONT-SAINT-GUIBERT, Belgium, May 17, 2022 (GLOBE NEWSWIRE) -- Celyad Oncology SA (Euronext & Nasdaq: CYAD) (the “Company”), a clinical-stage biotechnology company focused on the discovery and...
Esperion to Participate in Upcoming H.C. Wainwright Global Investment Conference
17 mai 2022 08h00 HE
|
Esperion Therapeutics, Inc.
ANN ARBOR, Mich., May 17, 2022 (GLOBE NEWSWIRE) -- Esperion (NASDAQ: ESPR), today announced that President and Chief Executive Officer, Sheldon Koenig, will participate in a fireside chat at the...
Monopar to Present at the H.C. Wainwright BioConnect Conference
07 janv. 2022 07h05 HE
|
Monopar Therapeutics Inc.
WILMETTE, Ill., Jan. 07, 2022 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (Nasdaq: MNPR), a clinical-stage biopharmaceutical company focused on developing proprietary therapeutics designed to...
Codiak BioSciences to Present at the H.C. Wainwright Virtual BioConnect 2022 Conference
06 janv. 2022 09h00 HE
|
Codiak BioSciences, Inc.
CAMBRIDGE, Mass., Jan. 06, 2022 (GLOBE NEWSWIRE) -- Codiak BioSciences, Inc. (Nasdaq: CDAK), a clinical-stage biopharmaceutical company pioneering the development of exosome-based therapeutics as a...
Imara to Present at the H.C. Wainwright BioConnect 2022 Virtual Conference
05 janv. 2022 07h00 HE
|
Imara, Inc.
BOSTON, Jan. 05, 2022 (GLOBE NEWSWIRE) -- Imara Inc. (Nasdaq: IMRA), a clinical-stage biopharmaceutical company dedicated to developing and commercializing novel therapeutics to treat subjects...
Yield10 Bioscience to Present at the H.C. Wainwright Bioconnect Virtual Conference
04 janv. 2022 08h30 HE
|
Yield10 Bioscience, Inc.
WOBURN, Mass., Jan. 04, 2022 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq: YTEN), an agricultural bioscience company, announced today that President and CEO Oliver Peoples, Ph.D. will give a...